Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
40
FBT Quote, Financials, Valuation and Earnings
Last price:
$166.70
Seasonality move
:
5.1%
Day range:
$165.82 - $168.32
52-week range:
$140.36 - $179.67
Dividend yield:
0.7%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
13.1K
Avg. volume:
25.6K
1-year change:
6.75%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
|
-- | -- | -- | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$167.98 | -- | -- | -- | $1.17 | 0.7% | -- |
|
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
|
$17.54 | -- | -- | -- | $0.00 | 0% | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
$106.01 | -- | -- | -- | $0.09 | 0.41% | -- |
|
IBB
iShares Biotechnology ETF
|
$134.67 | -- | -- | -- | $0.06 | 0.29% | -- |
|
IHI
iShares US Medical Devices ETF
|
$59.56 | -- | -- | -- | $0.11 | 0.46% | -- |
|
IYH
iShares US Healthcare ETF
|
$59.15 | -- | -- | -- | $0.20 | 1.23% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 1.249 | -- | -- |
|
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
|
-- | 1.528 | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | 1.296 | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | 1.446 | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | 1.148 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | 0.983 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
EKG
First Trust Nasdaq Lux Digi Health Solutions ETF
|
-- | -- | -- | -- | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | -- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
First Trust NYSE Arca Biotechnology Index Fund vs. Competitors
-
Which has Higher Returns FBT or EKG?
First Trust Nasdaq Lux Digi Health Solutions ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat First Trust Nasdaq Lux Digi Health Solutions ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF-- -- -- -
What do Analysts Say About FBT or EKG?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Nasdaq Lux Digi Health Solutions ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than First Trust Nasdaq Lux Digi Health Solutions ETF, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than First Trust Nasdaq Lux Digi Health Solutions ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF0 0 0 -
Is FBT or EKG More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.671, which suggesting that the stock is 32.903% less volatile than S&P 500. In comparison First Trust Nasdaq Lux Digi Health Solutions ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FBT or EKG?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. First Trust Nasdaq Lux Digi Health Solutions ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. First Trust Nasdaq Lux Digi Health Solutions ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or EKG?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than First Trust Nasdaq Lux Digi Health Solutions ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than First Trust Nasdaq Lux Digi Health Solutions ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while First Trust Nasdaq Lux Digi Health Solutions ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for First Trust Nasdaq Lux Digi Health Solutions ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- EKGFirst Trust Nasdaq Lux Digi Health Solutions ETF-- -- -- --
-
Which has Higher Returns FBT or FXH?
First Trust Health Care AlphaDEX Fund has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat First Trust Health Care AlphaDEX Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- FXHFirst Trust Health Care AlphaDEX Fund-- -- -- -
What do Analysts Say About FBT or FXH?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Health Care AlphaDEX Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than First Trust Health Care AlphaDEX Fund, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than First Trust Health Care AlphaDEX Fund.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 FXHFirst Trust Health Care AlphaDEX Fund0 0 0 -
Is FBT or FXH More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.671, which suggesting that the stock is 32.903% less volatile than S&P 500. In comparison First Trust Health Care AlphaDEX Fund has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.906%.
-
Which is a Better Dividend Stock FBT or FXH?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. First Trust Health Care AlphaDEX Fund offers a yield of 0.41% to investors and pays a quarterly dividend of $0.09 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. First Trust Health Care AlphaDEX Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or FXH?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than First Trust Health Care AlphaDEX Fund quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than First Trust Health Care AlphaDEX Fund's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while First Trust Health Care AlphaDEX Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for First Trust Health Care AlphaDEX Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- FXHFirst Trust Health Care AlphaDEX Fund-- -- -- --
-
Which has Higher Returns FBT or IBB?
iShares Biotechnology ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- IBBiShares Biotechnology ETF-- -- -- -
What do Analysts Say About FBT or IBB?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than iShares Biotechnology ETF, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than iShares Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 IBBiShares Biotechnology ETF0 0 0 -
Is FBT or IBB More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.671, which suggesting that the stock is 32.903% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.740, suggesting its less volatile than the S&P 500 by 26.046%.
-
Which is a Better Dividend Stock FBT or IBB?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. iShares Biotechnology ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.06 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or IBB?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- IBBiShares Biotechnology ETF-- -- -- --
-
Which has Higher Returns FBT or IHI?
iShares US Medical Devices ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- IHIiShares US Medical Devices ETF-- -- -- -
What do Analysts Say About FBT or IHI?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than iShares US Medical Devices ETF, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than iShares US Medical Devices ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 IHIiShares US Medical Devices ETF0 0 0 -
Is FBT or IHI More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.671, which suggesting that the stock is 32.903% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 0.904, suggesting its less volatile than the S&P 500 by 9.601%.
-
Which is a Better Dividend Stock FBT or IHI?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. iShares US Medical Devices ETF offers a yield of 0.46% to investors and pays a quarterly dividend of $0.11 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or IHI?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- IHIiShares US Medical Devices ETF-- -- -- --
-
Which has Higher Returns FBT or IYH?
iShares US Healthcare ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About FBT or IYH?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than iShares US Healthcare ETF, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is FBT or IYH More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.671, which suggesting that the stock is 32.903% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.453%.
-
Which is a Better Dividend Stock FBT or IYH?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. iShares US Healthcare ETF offers a yield of 1.23% to investors and pays a quarterly dividend of $0.20 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or IYH?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
